Shandong Pharmaceutical Glass operates within the Pressed and blown glass sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Pharmaceutical Glass with three other
companies in this sector in China:
Jiangsu Changhai Composite Materials Co Ltd
sales of 1.77 billion Chinese Renmimbi [US$266.96 million]
of which 72%
was Glass Fibre),
Jiangsu Xiuqiang Glasswork Co Ltd
(1.15 billion Chinese Renmimbi [US$173.22 million]
of which 89%
was Glass Further Processing), and
Anhui Deli Household Glass Co Ltd
(871.89 million Chinese Renmimbi [US$131.66 million]
of which 100%
was Glass and Glass Products).
During the year ended December of 2016, sales at
Shandong Pharmaceutical Glass were 2.06 billion Chinese Renmimbi (US$310.67 million).
increase of 19.4%
versus 2015, when the company's sales were 1.72 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shandong Pharmaceutical Glass
(and since 2011, sales have increased a total of 47%).
Sales of Trading saw an increase
that was more than double the company's growth rate: sales were up
152.0% in 2016, from
66.32 million Chinese Renmimbi to 167.15 million Chinese Renmimbi.